Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: NoZAJICEK, John.Multiple sclerosis. 2014, Vol 20, Num 9, pp 1165-1166, issn 1352-4585, 2 p.Article

MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: NoEBERS, George C.Multiple sclerosis. 2014, Vol 20, Num 3, pp 282-283, issn 1352-4585, 2 p.Article

Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: YesCOOTE, Susan.Multiple sclerosis. 2014, Vol 20, Num 2, pp 143-144, issn 1352-4585, 2 p.Article

Assessing upper limb function in multiple sclerosisLAMERS, Ilse; FEYS, Peter.Multiple sclerosis. 2014, Vol 20, Num 7, pp 775-784, issn 1352-4585, 10 p.Article

Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosisPROSPERING, Luca; PETSAS, Nikolaos; RAZ, Eytan et al.Multiple sclerosis. 2014, Vol 20, Num 1, pp 81-90, issn 1352-4585, 10 p.Article

Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosisPARISI, Laura; ROCCA, Maria A; MATTIOLI, Flavia et al.Multiple sclerosis. 2014, Vol 20, Num 6, pp 686-694, issn 1352-4585, 9 p.Article

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosisSMOLDERS, Joost; PEELEN, Evelyn; THEWISSEN, Mariëlle et al.Multiple sclerosis. 2014, Vol 20, Num 4, pp 433-437, issn 1352-4585, 5 p.Article

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis riskSTRAUTINS, K; TSCHOCHNER, M; JAMES, I et al.Multiple sclerosis. 2014, Vol 20, Num 3, pp 286-294, issn 1352-4585, 9 p.Article

Cortical plasticity predicts recovery from relapse in multiple sclerosisMORI, Francesco; KUSAYANAGI, Hajime; NICOLETTI, Carolina Gabri et al.Multiple sclerosis. 2014, Vol 20, Num 4, pp 451-457, issn 1352-4585, 7 p.Article

Disease course heterogeneity and OCT in multiple sclerosisBALK, L. J; TEWARIE, P; KILLESTEIN, J et al.Multiple sclerosis. 2014, Vol 20, Num 9, pp 1198-1206, issn 1352-4585, 9 p.Article

Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?MAILLART, Elisabeth; LOUAPRE, Céline; LUBETZKI, Catherine et al.Multiple sclerosis. 2014, Vol 20, Num 4, pp 505-509, issn 1352-4585, 5 p.Article

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisAXELSSON, Markus; MALMESTRÖM, Clas; GUNNARSSON, Martin et al.Multiple sclerosis. 2014, Vol 20, Num 1, pp 43-50, issn 1352-4585, 8 p.Article

Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trialGIORDANO, A; LUGARESI, A; CONFALONIERI, P et al.Multiple sclerosis. 2014, Vol 20, Num 9, pp 1234-1243, issn 1352-4585, 10 p.Article

Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warningCAPOBIANCO, Marco; PICCOLI, Giorgina; VIGOTTI, Federica Neve et al.Multiple sclerosis. 2014, Vol 20, Num 7, pp 889-891, issn 1352-4585, 3 p.Article

Lifestyle physical activity in persons with multiple sclerosis: the new kid on the MS blockMOTL, Robert W.Multiple sclerosis. 2014, Vol 20, Num 8, pp 1025-1029, issn 1352-4585, 5 p.Article

Magnetic resonance imaging in neuromyelitis opticaTACKLEY, George; KUKER, Wilhelm; PALACE, Jacqueline et al.Multiple sclerosis. 2014, Vol 20, Num 9, pp 1153-1164, issn 1352-4585, 12 p.Article

Milder multiple sclerosis course in patients with concomitant inflammatory bowel diseaseZEPHIR, Hélène; GOWER-ROUSSEAU, Corinne; ALLEZ, Matthieu et al.Multiple sclerosis. 2014, Vol 20, Num 8, pp 1135-1139, issn 1352-4585, 5 p.Article

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort studyARRU, Giannina; LEONI, Stefania; PUGLIATTI, Maura et al.Multiple sclerosis. 2014, Vol 20, Num 2, pp 174-182, issn 1352-4585, 9 p.Article

Predictors and dynamics of postpartum relapses in women with multiple sclerosisHUGHES, Stella E; SPELMAN, Tim; GRAMMOND, Pierre et al.Multiple sclerosis. 2014, Vol 20, Num 6, pp 739-746, issn 1352-4585, 8 p.Article

Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosisPILUTTI, L. A; DLUGONSKI, D; SANDROFF, B. M et al.Multiple sclerosis. 2014, Vol 20, Num 5, pp 594-601, issn 1352-4585, 8 p.Article

Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trialWICKSTRÖM, Anne; DAHLE, Charlotte; VRETHEM, Magnus et al.Multiple sclerosis. 2014, Vol 20, Num 8, pp 1095-1101, issn 1352-4585, 7 p.Article

The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on ageSALZER, Jonatan; STENLUND, Hans; SUNDSTRÖM, Peter et al.Multiple sclerosis. 2014, Vol 20, Num 6, pp 747-750, issn 1352-4585, 4 p.Article

The link between resting-state functional connectivity and cognition in MS patientsCRUZ-GOMEZ, Alvaro J; VENTURA-CAMPOS, Noelia; BELENGUER, Antonio et al.Multiple sclerosis. 2014, Vol 20, Num 3, pp 338-348, issn 1352-4585, 11 p.Article

6th PACTRIMS INVITED LECTUREMultiple sclerosis. 2014, Vol 20, Num 7, pp 901-960, issn 1352-4585, 60 p.Conference Paper

A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)CARROLL, W. M; SAIDA, T; BATES, D et al.Multiple sclerosis. 2013, Vol 19, Num 10, pp 1371-1380, issn 1352-4585, 10 p.Article